442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Argan reported fourth quarter and fiscal 2025 results for the period ended January 31, 2025. Quarterly revenue rose 41% to $232.5 million, and net income was $31.4 million, or $2.22 per diluted share, compared with $0.89 a year earlier. For the full year, revenue rose 52.5% to $874.2 million and net income was $85.5 million, or $6.15 per diluted share.
Q4 gross margin was 20.5%, up from 14.4% a year earlier; EBITDA was $39.3 million versus $17.6 million
Fiscal 2025 net income was $85.5 million, or $6.15 per diluted share, versus $32.4 million, or $2.39, in fiscal 2024
Project backlog was $1.4 billion at January 31, 2025, up from $757 million a year earlier; the company reported no debt
Quarterly cash dividend was $0.375 per share, up from $0.300 a year earlier
Paychex reported third-quarter fiscal 2025 results for the period ended February 28, 2025, with total revenue up 5% to $1.5 billion and diluted earnings per share up 4% to $1.43. The company also updated its fiscal 2025 outlook, now expecting PEO and Insurance Solutions revenue growth of 6.0% to 6.5% and an adjusted operating margin of about 43%, while the pending Paycor acquisition, expected to close in April 2025, is excluded from that outlook.
Total revenue was $1,509.0 million for the quarter, up 5% from $1,439.3 million a year earlier.
Diluted EPS was $1.43, up 4%; adjusted diluted EPS was $1.49, up 8%.
Fiscal 2025 outlook: PEO and Insurance Solutions revenue growth of 6.0% to 6.5%; adjusted operating margin about 43%.
The Paycor acquisition, agreed January 7, 2025, is expected to close in April 2025; the Hart-Scott-Rodino waiting period expired February 27, 2025.
Cintas reported fiscal 2025 third-quarter revenue of $2.61 billion, up 8.4%, and diluted EPS of $1.13, up 17.7% from $0.96 a year earlier. The company raised its fiscal 2025 diluted EPS guidance to $4.36 to $4.40 from $4.28 to $4.34, while narrowing its revenue guidance to $10.280 billion to $10.305 billion.
Q3 net income was $463.5 million, up 16.6%, and gross margin was 50.6% of revenue versus 49.4% a year earlier.
Q3 operating income included a $15.0 million gain on the sale of property and equipment; the prior-year quarter included a $15.0 million class action settlement charge.
Fiscal 2025 diluted EPS guidance rose to $4.36 to $4.40 from $4.28 to $4.34.
Fiscal 2025 revenue guidance is $10.280 billion to $10.305 billion, versus the prior $10.255 billion to $10.320 billion; the top end was lowered by $15.0 million due to currency effects.
Chewy reported fiscal fourth-quarter and full-year 2024 results, with net sales up 14.9% in Q4 and 6.4% for the year. Q4 GAAP net income and diluted EPS declined year over year, while adjusted EBITDA rose 44% and full-year net income increased, helped by a $241.0 million income tax benefit. Both quarter and year include an extra week, which the company notes affects the comparisons.
Q4 net sales of $3.25 billion, up 14.9% year over year (14-week quarter)
Q4 net income of $22.8 million and diluted EPS of $0.05, versus $31.9 million and $0.07 a year earlier
Q4 adjusted EBITDA of $124.5 million, up $38.1 million; full-year net income of $392.7 million
Fiscal 2024 repurchases of common stock totaled $942.8 million
Enerpac Tool Group reported fiscal second-quarter results for the three months ended February 28, 2025, with net sales of $145.5 million, up 5.1% from the prior year, and diluted EPS of $0.38 versus $0.33. Adjusted EBITDA slipped to $33.8 million from $34.3 million as gross margin declined 110 basis points, and the company reiterated its fiscal 2025 guidance. Shareholders see higher reported earnings alongside continued margin pressure.
Net sales were $145.5 million, up 5.1%, with organic sales up 5.0%.
Net earnings were $20.9 million, or $0.38 per diluted share, versus $17.9 million, or $0.33, a year earlier.
Gross profit margin fell 110 basis points to 50.5%; adjusted EBITDA was $33.8 million versus $34.3 million.
Fiscal 2025 guidance was reiterated: net sales of $610 million to $625 million and adjusted EBITDA of $150 million to $160 million.
Jabil reported preliminary, unaudited second-quarter fiscal 2025 results with net revenue of $6.7 billion, roughly flat with $6.8 billion a year earlier, and core diluted EPS of $1.94, up from $1.68. GAAP diluted EPS fell to $1.06 from $7.31 because the prior-year quarter included a $944 million divestiture gain. The company also raised its fiscal 2025 outlook, with core diluted EPS now expected at $8.95 and third-quarter net revenue guided to $6.7 billion to $7.3 billion.
Q2 net revenue $6.7 billion ($6,728 million) versus $6,767 million a year earlier
Q2 core diluted EPS $1.94 versus $1.68; GAAP diluted EPS $1.06 versus $7.31, which included a prior-year divestiture gain
Fiscal 2025 outlook: net revenue $27.9 billion, core operating margin 5.4%, core diluted EPS $8.95, adjusted free cash flow $1.2 billion or more
Q3 fiscal 2025 guidance: net revenue $6.7 billion to $7.3 billion; core diluted EPS $2.08 to $2.48
Darden reported fiscal third-quarter 2025 results for the quarter ended February 23, 2025, with sales up 6.2% and diluted earnings per share from continuing operations up from $2.60 to $2.74. The company also updated its fiscal 2025 outlook, projecting adjusted diluted EPS of $9.45 to $9.52, and declared a $1.40 quarterly dividend.
Q3 sales rose 6.2% to $3.2 billion, with consolidated same-restaurant sales up 0.7%
Adjusted diluted EPS from continuing operations was $2.80, up 6.9%, excluding $0.06 of Chuy's transaction and integration costs
Fiscal 2025 outlook: total sales of about $12.1 billion and adjusted diluted EPS of $9.45 to $9.52
Quarterly dividend of $1.40 per share is payable May 1, 2025; $53 million of stock repurchased in the quarter
Williams-Sonoma reported fourth-quarter fiscal 2024 net revenues of $2.46 billion, up from $2.28 billion a year earlier, with diluted EPS of $3.28 versus $2.72 and a record Q4 operating margin of 21.5%. The company also raised its quarterly dividend 16% to $0.66 per share, and its fiscal 2025 outlook projects net revenues from -1.5% to +1.5% and comparable revenue from flat to +3.0%.
Q4 comparable brand revenue rose 3.1%, and full-year fiscal 2024 comparable brand revenue fell 1.6%.
Q4 diluted EPS was $3.28 versus $2.72 a year earlier; full-year fiscal 2024 diluted EPS was $8.79.
Quarterly dividend increased 16% to $0.66 per share, payable May 24, 2025, to holders of record on April 17, 2025.
Fiscal 2025 outlook: net revenues -1.5% to +1.5%, comparable revenue flat to +3.0%, operating margin 17.4% to 17.8%.
HealthEquity reported fiscal 2025 results for the year ended January 31, 2025, with revenue of $1.20 billion (up 20%) and GAAP net income of $96.7 million, or $1.09 per diluted share, up from $55.7 million, or $0.64, a year earlier. Fourth-quarter net income was flat at $26.4 million, while the company guided to fiscal 2026 revenue of $1.280 billion to $1.305 billion and GAAP net income per diluted share of $1.85 to $2.01.
Fiscal 2025 revenue of $1.20 billion, up 20% from $999.6 million; Adjusted EBITDA of $471.8 million, up 28%.
Fourth-quarter revenue of $311.8 million, up 19%; net income of $26.4 million, unchanged from the prior-year quarter.
Fiscal 2026 outlook: revenue of $1.280 billion to $1.305 billion; GAAP net income per diluted share of $1.85 to $2.01; Adjusted EBITDA of $525 million to $545 million.
Completed the BenefitWallet HSA portfolio acquisition for a purchase price of $425.0 million and repurchased 1.4 million shares for $122.2 million during the year.
Docusign reported fourth-quarter and fiscal 2025 results for the periods ended January 31, 2025, with total revenue up 9% in the quarter and 8% for the year. The company also issued revenue guidance for the quarter ending April 30, 2025 and for fiscal 2026, which shareholders can use as a reference point for future results.
Q4 GAAP diluted EPS was $0.39 versus $0.13 a year earlier; non-GAAP diluted EPS was $0.86 versus $0.76.
Fiscal 2025 GAAP net income was $1.07 billion, including an income tax benefit of $819.9 million; GAAP diluted EPS was $5.08 versus $0.36.
Guidance: quarter ending April 30, 2025 total revenue of $745 million to $749 million; fiscal 2026 total revenue of $3,129 million to $3,141 million.
Fiscal 2025 stock repurchases were $683.5 million, compared with $145.5 million a year earlier.
Adobe reported first quarter fiscal 2025 results for the period ended February 28, 2025, with revenue of $5.71 billion, up 10% year over year, and GAAP diluted earnings per share of $4.14 versus $1.36 a year earlier. The prior-year figure included a $1.0 billion Figma acquisition termination fee. The company reaffirmed its FY2025 financial targets, which keeps its full-year outlook unchanged.
Revenue was $5.71 billion, up 10% year over year, or 11% in constant currency.
Non-GAAP diluted EPS was $5.08, compared with $4.48 a year earlier; GAAP diluted EPS was $4.14.
Operating cash flow was $2.48 billion, and the company repurchased about 7.0 million shares during the quarter.
FY2025 targets were reaffirmed, including total revenue of $23.30 billion to $23.55 billion and non-GAAP EPS of $20.20 to $20.50.
ABM reported first-quarter fiscal 2025 revenue of $2.1 billion, up 2.2%, with net income of $43.6 million, or $0.69 per diluted share, versus $0.70 a year earlier. The company raised the low end of its full-year adjusted EPS outlook by $0.05 to a range of $3.65 to $3.80 and declared a $0.265 quarterly dividend, but free cash flow was negative $122.9 million, which management attributed mainly to a temporary working capital increase during its new ERP system transition.
Revenue of $2.1 billion, up 2.2%, including 1.6% organic growth; Technical Solutions revenue rose 21.9% and Aviation rose 8.2%
Net income of $43.6 million ($0.69 per diluted share) vs. $44.7 million ($0.70) a year earlier; adjusted EPS of $0.87 vs. $0.86
Fiscal 2025 adjusted EPS outlook now $3.65 to $3.80; adjusted EBITDA margin forecast unchanged at 6.3% to 6.5%
Free cash flow was negative $122.9 million vs. negative $13.7 million; quarterly dividend of $0.265 payable May 5, 2025 to holders of record April 3, 2025
Casey's reported third-quarter results for the period ended January 31, 2025, with diluted EPS flat at $2.33 and net income flat at $87.1 million, while EBITDA rose 11.4% to $242.4 million. The company now expects fiscal 2025 EBITDA to increase about 11%, and its Board approved a $0.50 quarterly dividend, so shareholders see stable per-share earnings alongside higher operating profit before interest, taxes, depreciation and amortization.
Diluted EPS $2.33, flat year over year; net income $87.1 million; total revenue $3.9 billion
EBITDA $242.4 million, up 11.4%, driven by higher inside and fuel gross profit; higher interest expense from Fikes debt offset gains
Inside same-store sales up 3.7%; same-store fuel gallons up 1.8%; fuel margin 36.4 cents per gallon
Quarterly dividend of $0.50 per share payable May 15, 2025; no shares repurchased in the third quarter
For the fiscal second quarter ended February 1, 2025, UNFI reported net sales up 4.9% to $8.2 billion and a net loss of $3 million, or $0.05 per diluted share, versus a $15 million loss a year earlier. The company raised its fiscal 2025 outlook for most metrics, including Adjusted EPS of $0.70 to $0.90, up from $0.40 to $0.80. Both sales and per-share results improved, though the company still posted a GAAP loss for the quarter.
Net sales rose 4.9% to $8.2 billion, driven by a 3% increase in wholesale unit volumes and inflation.
Net loss narrowed to $3 million ($0.05 per diluted share) from $15 million ($0.25); Adjusted EPS was $0.22 versus $0.07.
Adjusted EBITDA rose 13.3% to $145 million; net debt to Adjusted EBITDA ratio fell to 3.7x from 4.3x a year earlier.
Fiscal 2025 outlook raised from the December 10, 2024 guidance: net sales now $31.3 billion to $31.7 billion and free cash flow above $150 million.
DICK'S Sporting Goods reported fourth quarter and full year 2024 results, with fourth quarter net sales of $3.89 billion, up 0.5%, and full year diluted EPS of $14.05, up from $12.18. The company guided 2025 diluted EPS to $13.80 to $14.40 and raised its quarterly dividend 10% to $1.2125 per share, and its board approved a new $3 billion share repurchase program.
Q4 comparable sales rose 6.4%; the fourth quarter had 13 weeks versus 14 in the prior-year period, and the calendar shift reduced net sales by about $30 million.
Q4 GAAP diluted EPS was $3.62, up from $3.57; non-GAAP diluted EPS was $3.62 versus $3.85 a year earlier.
2025 outlook: comparable sales growth of 1.0% to 3.0%, net sales of $13.6 billion to $13.9 billion, and diluted EPS of $13.80 to $14.40.
Dividend of $1.2125 per share payable April 11, 2025, to holders of record on March 28, 2025; new $3 billion repurchase program is in addition to the remaining amount of the $2 billion program authorized December 16, 2021.
StandardAero reported fourth-quarter and full-year 2024 results, with revenue up 21.8% in the quarter and 14.8% for the year. Full-year net income was $11.0 million, compared with a net loss of $35.1 million in 2023, although the fourth-quarter net loss widened to $14.1 million from $4.6 million a year earlier. The company also initiated 2025 guidance calling for revenue of $5.8 billion to $5.95 billion and Adjusted EBITDA of $770 million to $790 million.
Q4 2024 revenue was $1,409.6 million, up 21.8% from $1,157.8 million; Q4 net loss was $14.1 million versus $4.6 million a year earlier.
Full-year 2024 net income was $11.0 million versus a net loss of $35.1 million in 2023; full-year Adjusted EBITDA was $690.5 million, up 23.1%.
2025 guidance: revenue of $5.8 billion to $5.95 billion, Adjusted EBITDA of $770 million to $790 million, and free cash flow of $155 million to $175 million.
IPO completed October 2, 2024 at $24.00 per share; net primary proceeds of $1.2 billion were used to pay down debt.
Vail Resorts reported fiscal 2025 second-quarter results for the three months ended January 31, 2025, with net income attributable to the company of $245.5 million, up from $219.3 million a year earlier. The company also updated fiscal 2025 guidance, now expecting net income of $257 million to $309 million, and said Resort Reported EBITDA midpoint is unchanged excluding a $7 million foreign currency impact.
Q2 net income attributable to Vail Resorts was $245.5 million, or $6.56 per diluted share, versus $219.3 million, or $5.76 per diluted share, a year earlier
Resort Reported EBITDA was $459.7 million, up 8.1% from the prior year period
Fiscal 2025 guidance: net income of $257 million to $309 million and Resort Reported EBITDA of $841 million to $877 million, including a $7 million foreign currency impact
Season-to-date skier visits through March 2, 2025 were down 2.5% compared to the prior year period
DXP Enterprises reported fourth-quarter and fiscal 2024 results in a press release furnished under Item 2.02. Fourth-quarter sales rose to $470.9 million from $407.0 million, and diluted EPS rose to $1.29 from $0.94. For the full year, sales grew 7.4 percent to $1.8 billion and net income reached $70.5 million, up from $68.8 million, so shareholders saw higher sales and profit on both measures.
Q4 2024 sales were $470.9 million versus $407.0 million in Q4 2023; diluted EPS was $1.29 versus $0.94.
Fiscal 2024 diluted EPS was $4.22 versus $3.89 in fiscal 2023; net income was $70.5 million versus $68.8 million.
Fiscal 2024 free cash flow was $77.1 million, down from $94.0 million in fiscal 2023.
The company refinanced its Senior Secured Term Loan B, raising $649.5 million, and repurchased 0.6 million shares for $28.8 million in fiscal 2024.
Abercrombie & Fitch reported fourth quarter and fiscal 2024 results on March 5, 2025, with full-year net sales up 16% to $4.95 billion and diluted earnings per share of $10.69, compared with $6.22 a year earlier. The Board also authorized a new $1.3 billion share repurchase program with no expiration date, and the company gave fiscal 2025 guidance of 3% to 5% net sales growth and net income per diluted share of $10.40 to $11.40.
Fourth quarter net sales were $1.58 billion, up 9%, with comparable sales up 14%.
Full-year operating margin was 15.0%, up from 11.3% in fiscal 2023.
Full-year diluted EPS was $10.69 versus $6.22; the 2025 outlook is $10.40 to $11.40.
The new $1.3 billion authorization replaces the 2021 program; the company expects $400 million in share repurchases in 2025.
CooperCompanies reported fiscal first-quarter 2025 results for the period ended January 31, 2025, with revenue up 4% to $964.7 million and GAAP diluted EPS of $0.52, compared with $0.41 a year earlier. The company also raised the low end of its fiscal 2025 non-GAAP diluted EPS guidance to $3.94 to $4.02, from $3.92 to $4.02, which gives shareholders a higher expected earnings floor for the year.
Q1 revenue of $964.7 million, up 4% from $931.6 million a year earlier; up 5% in constant currency and organically
GAAP diluted EPS of $0.52 vs. $0.41; non-GAAP diluted EPS of $0.92 vs. $0.85
Fiscal 2025 non-GAAP diluted EPS guidance raised to $3.94 to $4.02 from $3.92 to $4.02
Fiscal 2025 total revenue guidance of $4,080 million to $4,158 million, with organic growth of 6% to 8%
Gap Inc. reported fourth-quarter fiscal 2024 net income of $206 million, or $0.54 per diluted share, up from $185 million, or $0.49, a year earlier, while net sales fell 3% to $4.1 billion, partly because the quarter had 13 weeks versus 14 a year earlier. For the full year, net sales rose 1% to $15.1 billion and net income reached $844 million, or $2.20 per diluted share, compared with $502 million, or $1.34. The company guided fiscal 2025 net sales growth of 1% to 2% and operating income growth of 8% to 10%.
Fourth-quarter comparable sales rose 3%; net sales of $4.1 billion were down 3%, with about 7 percentage points of negative impact from the calendar shift.
Fourth-quarter operating income was $259 million, an operating margin of 6.2%, versus $214 million a year earlier.
Full-year operating income was $1.1 billion versus $560 million; free cash flow was $1.0 billion.
Fiscal 2025 outlook: net sales growth of 1% to 2% and operating income growth of 8% to 10%; first-quarter net sales expected flat to up slightly.
Burlington Stores reported fourth-quarter fiscal 2024 comparable store sales growth of 6%, above its 0% to 2% guidance, and adjusted EPS of $4.13, up 12% and above its $3.55 to $3.75 guidance range. For full fiscal 2024, adjusted EPS was $8.35, up 34%, but the company said the 2025 outlook is very uncertain and guided first-quarter adjusted EPS of $1.30 to $1.45, below the $1.42 reported a year earlier.
Q4 net income was $261 million, or $4.02 per diluted share, versus $227 million, or $3.53 per share, in the prior year's 14-week period.
Q4 adjusted EPS was $4.13 versus guidance of $3.55 to $3.75.
Fiscal 2025 adjusted EPS is guided to $8.70 to $9.30, compared with $8.35 in fiscal 2024.
First-quarter fiscal 2025 adjusted EPS is guided to $1.30 to $1.45, compared with $1.42 a year earlier.
Kodiak Gas Services reported fourth-quarter 2024 net income attributable to common shareholders of $19.1 million, compared with a net loss of $6.9 million a year earlier, and full-year net income of $49.9 million versus $20.1 million in 2023. The company also issued 2025 guidance, including adjusted EBITDA of $685 million to $725 million, which gives shareholders a first benchmark for the coming year.
Q4 2024 total revenues were $309.5 million, up from $226.0 million in Q4 2023 but down from $324.6 million in Q3 2024.
Full-year 2024 adjusted EBITDA was $609.6 million, compared with $438.1 million in 2023.
2025 guidance: adjusted EBITDA of $685 million to $725 million and growth capital expenditures of $240 million to $280 million.
The company repurchased 1.4 million shares in 2024 at a weighted average price of $27.88 and reported $322.5 million available on its ABL Facility.
Veeva reported fourth-quarter revenue of $720.9 million, up 14% year over year, with GAAP diluted net income per share of $1.18 versus $0.90 a year earlier. For fiscal 2025, total revenue rose 16% to $2,746.6 million and GAAP net income rose 36% to $714.1 million, and the company gave first-quarter and fiscal 2026 guidance, which shareholders can compare with future results.
Q4 total revenue $720.9 million, up 14% from $630.6 million; subscription services revenue $608.6 million, up 17%
Q4 GAAP operating income $188.4 million, up 39%; non-GAAP operating income $307.7 million, up 29%
Fiscal 2025 GAAP diluted EPS $4.32 vs $3.22; non-GAAP diluted EPS $6.60 vs $4.84
Fiscal 2026 guidance: total revenues $3,040-$3,055 million and non-GAAP diluted EPS of approximately $7.32; Q1 fiscal 2026 non-GAAP EPS $1.74-$1.75
NCR Atleos reported fourth quarter 2024 revenue of $1.11 billion, up 1%, and GAAP net income attributable to Atleos of $46 million, compared with a loss of $165 million a year earlier. For full year 2024, revenue was $4.3 billion, up 3%, and GAAP diluted EPS was $1.23, compared with a loss of $1.90 in 2023. The company also issued 2025 guidance calling for constant-currency total revenue growth of 1% to 3%, Adjusted EBITDA growth of 7% to 10%, and non-GAAP diluted EPS growth of 21% to 27%.
Q4 2024 revenue $1.11 billion, up 1%; Q4 GAAP diluted EPS $0.61 versus a loss of $2.34 a year earlier
Full year 2024 operating cash flow $344 million; adjusted free cash flow-unrestricted $242 million
2025 guidance: total revenue growth 1% to 3% constant currency, with an estimated FX impact of -2%; adjusted free cash flow-unrestricted of $260 million to $300 million
Conference call scheduled for March 4, 2025 at 8:30 a.m. Eastern Time
Dave Inc. reported fourth quarter 2024 revenue of $100.9 million, up 38% from a year earlier, and net income of $16.8 million, compared with $0.2 million in the prior-year quarter. The company also issued 2025 guidance of $415 million to $435 million in GAAP operating revenue and $110 million to $120 million in Adjusted EBITDA, a non-GAAP measure.
Q4 2024 GAAP operating revenues, net: $100.9 million, up 38% year over year
Q4 2024 GAAP net income: $16.8 million, versus $0.2 million in Q4 2023; full-year 2024 net income was $57.9 million
Q4 2024 Adjusted EBITDA: $33.4 million, which the company says significantly exceeded the high end of its guidance
2025 guidance: revenue of $415 million to $435 million and Adjusted EBITDA of $110 million to $120 million
Okta reported fourth-quarter and full fiscal 2025 results for the period ended January 31, 2025, with revenue up 13% and a GAAP net profit in the quarter after a loss a year earlier. The company guided fiscal 2026 total revenue to $2.850 billion to $2.860 billion, or 9% to 10% growth, which is slower than the 15% full-year growth it reported for fiscal 2025.
Q4 fiscal 2025 total revenue was $682 million, up 13% year-over-year; subscription revenue was $670 million.
GAAP net income was $23 million, or $0.13 per diluted share, versus a GAAP net loss of $44 million a year earlier.
Non-GAAP diluted net income per share was $0.78, compared with $0.63 in the prior-year quarter.
For fiscal 2026, the company expects total revenue of $2.850 billion to $2.860 billion and non-GAAP diluted EPS of $3.15 to $3.20.
TG Therapeutics reported fourth-quarter and full-year 2024 results, with full-year total revenue of $329.0 million and net income of $23.4 million, compared with $233.7 million and $12.7 million in 2023. The company set a 2025 target of approximately $540 million in total global revenue and said its $311.0 million in cash, cash equivalents and investment securities, combined with projected BRIUMVI revenue, should fund the business under its current operating plan.
Q4 2024 total revenue was $108.2 million, compared with $44.0 million in Q4 2023; Q4 2024 net income was $23.3 million, compared with a net loss of $14.4 million.
Full-year 2024 total revenue was $329.0 million, compared with $233.7 million in 2023; 2023 included recognition of a one-time $140.0 million Neuraxpharm upfront payment.
2025 target total global revenue is approximately $540 million, including BRIUMVI U.S. net product revenue of approximately $525 million.
Cash, cash equivalents and investment securities were $311.0 million as of December 31, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.